HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Musculoskeletal evaluation in severe haemophilia A patients from Latin America.

Abstract
There is a paucity of literature on haemophilia treatment in Latin American countries, a region characterized by rapidly improving systems of care, but with substantial disparities in treatment between countries. The aim of this study was to evaluate the musculoskeletal status of haemophilia patients from Latin America and to examine the relationship between musculoskeletal status and treatment practices across countries. The Committee of Latin America on the Therapeutics of Inhibitor Groups conducted a survey of its member country representatives on key aspects of haemophilia treatment in 10 countries. Musculoskeletal status of patients was obtained during routine comprehensive evaluations between March 2009 and March 2011. Eligible patients had severe haemophilia A (factor VIII <1%) without inhibitors (<0.6 BU mL(-1) ) and were ≥5 years of age. Musculoskeletal status was compared between three groups of countries, based primarily on differences in the availability of long-term prophylaxis. Overall, 143 patients (5-66 years of age) were enrolled from nine countries. In countries where long-term prophylaxis had been available for at least 10 years (Group A), patients aged 5-10 years had significantly better mean World Federation of Hemophilia clinical scores, fewer target joints and fewer affected joints than patients from countries where long-term prophylaxis has been available for about 5 years (Group B) or was not available (Group C). In Latin America, the musculoskeletal status of patients with severe haemophilia without inhibitors has improved significantly in association with the provision of long-term prophylaxis. As more countries in Latin America institute this practice, further improvements are anticipated.
AuthorsM C Ozelo, P R Villaça, R Pérez-Bianco, M Candela, J Garcia-Chavez, B Moreno-Rodriguez, M B Rodrigues, I Rodriguez-Grecco, M H Solano, G Chumpitaz, M M Morales-Gana, A Ruiz-Sáez
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 20 Issue 1 Pg. e63-70 (Jan 2014) ISSN: 1365-2516 [Electronic] England
PMID24354487 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 The Authors Haemophilia Published by John Wiley & Sons Ltd.
Chemical References
  • Factor VIII
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Child
  • Child, Preschool
  • Factor VIII (administration & dosage, therapeutic use)
  • Hemarthrosis (diagnosis, etiology, therapy)
  • Hemophilia A (complications, drug therapy)
  • Humans
  • Latin America
  • Male
  • Middle Aged
  • Premedication
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: